Skip to main content
. 2013 Mar 13;84(2):297–307. doi: 10.1038/ki.2013.81

Figure 5.

Figure 5

Mesenchymal stem cells (MSCs) suppressed phosphorylated Smad2 (pSmad2) expression in rats with peritoneal fibrosis. (a) Immunohistochemical analysis of pSmad2 expression in peritoneal tissues on days 7 and 14 (original magnification × 200) in control rats, chlorhexidine gluconate (CG)-injected rats treated with vehicle alone, and CG-injected rats treated with MSCs. (b) The number of pSmad2+ cells increased until day 14 in CG-injected rats treated with vehicle alone, whereas it was significantly smaller on days 7 and 14 in CG-injected rats treated with MSCs. *P<0.01 versus control group, #P<0.05 versus CG+vehicle group.